Lista de obras - Min Yi - Dominio Público Uruguay

A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer ⬇️

artículo científico publicado el 21 de septiembre de 2012

Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer.

artículo científico

Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients

artículo científico publicado en 2016

Classification of Ipsilateral Breast Tumor Recurrences After Breast Conservation Therapy Can Predict Patient Prognosis and Facilitate Treatment Planning ⬇️

artículo científico publicado el 1 de marzo de 2011

Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer

artículo científico publicado en 2016

Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database

artículo científico publicado en 2019

Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States

artículo científico publicado en 2012

Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer.

artículo científico publicado en 2013

Comparison of clinicopathologic features and survival in young American women aged 18–39 years in different ethnic groups with breast cancer ⬇️

artículo científico publicado el 3 de septiembre de 2013

Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race

artículo científico publicado en 2014

Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer.

artículo científico publicado en 2017

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

artículo científico publicado en 2016

Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer

artículo científico publicado en 2016

Does Blue Dye Contribute to Success of Sentinel Node Mapping for Breast Cancer? ⬇️

artículo científico publicado el 19 de septiembre de 2010

Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence

artículo científico publicado en 2014

Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer

artículo científico publicado en 2013

Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision ⬇️

artículo científico publicado el 17 de enero de 2012

Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer.

artículo científico publicado en 2014

Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells.

scientific article published on 16 August 2013

Impact of Identification of Internal Mammary Sentinel Lymph Node Metastasis in Breast Cancer Patients

artículo científico publicado en 2013

Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy

artículo científico publicado en 2013

Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer ⬇️

artículo científico publicado el 30 de mayo de 2012

Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population ⬇️

artículo científico publicado el 2 de noviembre de 2012

Incidence and survival differences in esophageal cancer among ethnic groups in the United States

artículo científico publicado en 2017

Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?

scientific article published on 24 April 2015

Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event

artículo científico publicado en 2014

LMW-E/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1/2-mTOR Pathway in Breast Cancer Patients ⬇️

artículo científico publicado el 29 de marzo de 2012

Local, regional, and systemic recurrence rates in patients undergoing skin‐sparing mastectomy compared with conventional mastectomy ⬇️

artículo científico publicado el 13 de octubre de 2010

Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer

artículo científico publicado en 2012

Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection

artículo científico publicado en 2007

Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival

scientific article published on 01 August 2007

Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.

artículo científico publicado en 2011

Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction

artículo científico publicado en 2016

Organizing a breast cancer database: data management

artículo científico publicado en 2016

Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy

scientific article published on 06 December 2012

Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy

artículo científico publicado en 2016

Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database

artículo científico publicado en 2014

Predicting the extent of nodal disease in early-stage breast cancer

scientific article published on 24 May 2014

Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.

artículo científico publicado en 2009

Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study.

artículo científico publicado en 2017

Sentinel Lymph Node Dissection Is Technically Feasible in Older Breast Cancer Patients

artículo científico publicado en 2010

Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node

scientific article published on 01 October 2005

Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients

artículo científico publicado en 2009

Simultaneous inference of a misclassified outcome and competing risks failure time data

artículo científico publicado en 2015

Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction.

artículo científico publicado en 2012

The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer

artículo científico publicado en 2012

Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database

artículo científico publicado en 2010

Use of Hematopoietic Growth Factors in Elderly Lung Cancer Patients Receiving Chemotherapy: A SEER-Medicare-based Study.

artículo científico publicado en 2014

Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer

scientific article published on 26 May 2006

Which threshold for ER positivity? a retrospective study based on 9639 patients

artículo científico publicado en 2014

Lista de obras de Min Yi

A Bayesian model for misclassified binary outcomes and correlated survival data with applications to breast cancer ⬇️

Breast conservation in the setting of contemporary multimodality treatment provides excellent outcomes for patients with occult primary breast cancer.

Characteristics of Differently Located Colorectal Cancers Support Proximal and Distal Classification: A Population-Based Study of 57,847 Patients

Classification of Ipsilateral Breast Tumor Recurrences After Breast Conservation Therapy Can Predict Patient Prognosis and Facilitate Treatment Planning ⬇️

Comparative Analysis of Clinicopathologic Features of, Treatment in, and Survival of Americans with Lung or Bronchial Cancer

Comparative Analysis of Outcomes and Clinicopathological Characteristics of Synchronous and Metachronous Contralateral Breast Cancer: A Study of the SEER Database

Comparative analysis of clinicopathologic features, treatment, and survival of Asian women with a breast cancer diagnosis residing in the United States

Comparative analysis of lifestyle factors, screening test use, and clinicopathologic features in association with survival among Asian Americans with colorectal cancer.

Comparison of clinicopathologic features and survival in young American women aged 18–39 years in different ethnic groups with breast cancer ⬇️

Crossover effects of estrogen receptor status on breast cancer-specific hazard rates by age and race

Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer.

Cytoplasmic Cyclin E Predicts Recurrence in Patients with Breast Cancer

Cytoplasmic Cyclin E and Phospho-Cyclin-Dependent Kinase 2 Are Biomarkers of Aggressive Breast Cancer

Does Blue Dye Contribute to Success of Sentinel Node Mapping for Breast Cancer? ⬇️

Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence

Elafin, an inhibitor of elastase, is a prognostic indicator in breast cancer

Evaluation of a Breast Cancer Nomogram for Predicting Risk of Ipsilateral Breast Tumor Recurrences in Patients With Ductal Carcinoma in Situ After Local Excision ⬇️

Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer.

Hbo1 is a cyclin E/CDK2 substrate that enriches breast cancer stem-like cells.

Impact of Identification of Internal Mammary Sentinel Lymph Node Metastasis in Breast Cancer Patients

Impact of chemotherapy sequencing on local-regional failure risk in breast cancer patients undergoing breast-conserving therapy

Impact of internal mammary lymph node drainage identified by preoperative lymphoscintigraphy on outcomes in patients with stage I to III breast cancer ⬇️

Impact of the American College of Surgeons Oncology Group Z0011 Criteria Applied to a Contemporary Patient Population ⬇️

Incidence and survival differences in esophageal cancer among ethnic groups in the United States

Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?

Joint model for a diagnostic test without a gold standard in the presence of a dependent terminal event

LMW-E/CDK2 Deregulates Acinar Morphogenesis, Induces Tumorigenesis, and Associates with the Activated b-Raf-ERK1/2-mTOR Pathway in Breast Cancer Patients ⬇️

Local, regional, and systemic recurrence rates in patients undergoing skin‐sparing mastectomy compared with conventional mastectomy ⬇️

Long-term outcomes in patients with radiation-associated angiosarcomas of the breast following surgery and radiotherapy for breast cancer

Low locoregional failure rates in selected breast cancer patients with tumor-positive sentinel lymph nodes who do not undergo completion axillary dissection

Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival

Novel staging system for predicting disease-specific survival in patients with breast cancer treated with surgery as the first intervention: time to modify the current American Joint Committee on Cancer staging system.

Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic Reconstruction

Organizing a breast cancer database: data management

Other primary malignancies in breast cancer patients treated with breast conserving surgery and radiation therapy

Outcomes of Sentinel Lymph Node-Positive Breast Cancer Patients Treated with Mastectomy Without Axillary Therapy

Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database

Predicting the extent of nodal disease in early-stage breast cancer

Predictors of contralateral breast cancer in patients with unilateral breast cancer undergoing contralateral prophylactic mastectomy.

Risk of subsequent primary malignancies among patients with prior colorectal cancer: a population-based cohort study.

Sentinel Lymph Node Dissection Is Technically Feasible in Older Breast Cancer Patients

Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node

Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients

Simultaneous inference of a misclassified outcome and competing risks failure time data

Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction.

The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer

Trends in and outcomes from sentinel lymph node biopsy (SLNB) alone vs. SLNB with axillary lymph node dissection for node-positive breast cancer patients: experience from the SEER database

Use of Hematopoietic Growth Factors in Elderly Lung Cancer Patients Receiving Chemotherapy: A SEER-Medicare-based Study.

Use of lymphoscintigraphy defines lymphatic drainage patterns before sentinel lymph node biopsy for breast cancer

Which threshold for ER positivity? a retrospective study based on 9639 patients